Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions
Journal of Personalized Medicine · 04.11.2024 · 14 (11) · 1092
DOI: 10.3390/jpm14111092 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 04.11.2024. Verfasst von Eslam Ramadan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, H-6720 Szeged, Hungary. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
After the COVID-19 pandemic, mRNA-based vaccines have emerged as a revolutionary technology in immunization and vaccination. These vaccines have shown remarkable efficacy against the virus and opened up avenues for their possible application in other diseases. This has renewed interest and investment in mRNA vaccine research and development, attracting the scientific community to explore all its other applications beyond infectious diseases. Recently, researchers have focused on the possibility of adapting this vaccination approach to cancer immunotherapy. While there is a huge potential, challenges still remain in the design and optimization of the synthetic mRNA molecules and the lipid nanoparticle delivery system required to ensure the adequate elicitation of the immune response and the successful eradication of tumors. This review points out the basic mechanisms of mRNA-LNP vaccines in cancer immunotherapy and recent approaches in mRNA vaccine design. This review displays the current mRNA modifications and lipid nanoparticle components and how these factors affect vaccine efficacy. Furthermore, this review discusses the future directions and clinical applications of mRNA-LNP vaccines in cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, H-6720 Szeged, Hungary.
- Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
- Department of Clinical Pharmacy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
- Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
ORCID-Profile: Eslam Ramadan, Ali Ahmed
Zitieren
APA
Ramadan, E., Ahmed, A., & Naguib, Y. W. (2024). Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions. Journal of Personalized Medicine, 14(11), 1092. https://doi.org/10.3390/jpm14111092
Vancouver
Ramadan E, Ahmed A, Naguib YW. Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions. Journal of Personalized Medicine. 2024;14(11):1092. doi:10.3390/jpm14111092
BibTeX
@article{Ramadan2024,
author = {Ramadan, Eslam and Ahmed, Ali and Naguib, Youssef Wahib},
title = {Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions},
journal = {Journal of Personalized Medicine},
year = {2024},
volume = {14},
number = {11},
pages = {1092},
doi = {10.3390/jpm14111092}
}
EUVIMED